Phylaxia 1912 to raise HUF 350 mln through share issue
The board of Hungarian veterinary-drug company Phylaxia 1912 Holding will raise the company's book equity by HUF 350 million to HUF 1.44 billion through an issue of 14 million dematerialized ordinary shares at a nominal value of HUF 25 per share, the company announced on Tuesday evening.
Phylaxia 1912 Holding said shareholders as of July 26 would be given preemptive rights to buy newly issued shares until August 11.
The issue is underwritten by Kálmán Böjthe, a Hungarian private individual domiciled in Germany.
Phylaxia 1912 Holding is a B-category issuer at the Budapest Stock Exchange.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.